Experimental basis for the prevention of breast cancer

European Journal of Cancer

Volumn 36, Issue 10, 2000, Pages 1275-1282

  Mehta, R G ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Carcinogenesis; Chemopreventive agents; Combination chemoprevention; Mammary lesions; Organ culture

Indexed keywords

17 ETHYNYL 11ALPHA METHOXYESTRADIOL; ALITRETINOIN; AMINOGLUTETHIMIDE; ANTINEOPLASTIC AGENT; BUTYRIC ACID; CARBENOXOLONE; CARCINOGEN; DEGUELIN; DIALLYL DISULFIDE; EFLORNITHINE; ELLAGIC ACID; FENRETINIDE; INDOMETACIN; ISOTRETINOIN; MELATONIN; MISOPROSTOL; MORIN; OLTIPRAZ; PIROXICAM; PRASTERONE; PROGESTERONE; QUERCETIN; RETINOL ACETATE; RO 24 5531; SACCHARATE CALCIUM; SARCOPHYTOL A; SELENIUM; SODIUM THIOSULFATE; TAMOXIFEN; THIOLUTIN; TOREMIFENE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER PREVENTION; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; FEMALE; MODEL; MOUSE; NONHUMAN; ORGAN CULTURE; PRECANCER; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOGENS; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED;

EID: 0034043183     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00100-3     Document Type: Conference Paper

References (44)

1. Kelloff GJ, Boone CW, Crowell JA, Stele VE, Lubet R, Sigman CC. Chemopreventive drug development: perspectives and progress. Cancer Epidemiology and Biomarkers Rev 1994, 3, 85-98.
2. Sporn MB, Hong KW. Recent advances in chemoprevention of cancer. Science 1997, 278, 1073-1077.
3. Kelloff GJ, Boone CW, Malone WF, Steele VE. Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute. In Wattenberg L, Lipkin M, Boone CW, Kelloff GJ, eds. Cancer Chemoprevention. Boca Raton, FL, CRC Press, 1992, 42-54.
4. Moon RC, Mehta RG, Rao KVN. Retinoids and experimental cancer. In Sporn MB, Goodman GS, Roberts AB, eds. The Retinoids 2nd edition. New York, NY, Raven Press, 1994, 574-598.
5. Steele VE, Sharma S, Mehta RG, et al. Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J Cellular Biochem 1996, 26S, 29-53.
6. Boone CW, Kelloff GJ. Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive intraepithelial neoplasia. J Cellular Biochem 1994, 19S, 10-23.
7. Wattenberg LW. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 1992, 52, 2085s-2091s.
8. Lin FK, Banerjee MR, Crump LR. Cell cycle related hormone carcinogen interaction during chemical carcinogen induction of nodule-like mammary lesions in organ culture. Cancer Res 1976, 36, 1607-1614.
9. Telang NT, Banerjee MR, lyer IP, Kundu AB. Neoplastic transformation of epithelial cells in whole mammary gland in vitro. Proc Natl Acad Sci USA 1979, 76, 5886-5890.
10. Mehta RG, Hawthorne ME, Steele VE. Induction and prevention of carcinogen induced precancerous lesions in mouse mammary gland organ culture. Methods in Cell Sci 1997, 19, 19-24.
11. Dickens MS, Custer RF, Sorof S. Retinoid prevents mammary gland transformation by carcinogen hydrocarbon I whole gland organ culture. Proc Natl Acad Sci 1979, 76, 5891-5897.
12. Mehta RG, Moon RC. Effects of 12-O-tetra decanoyl-phorbol13-acetate (TPA) on carcinogen-induced mammary lesions in organ culture. Cancer Res 1986, 46, 5832-5836.
13. Ip C. Mammary tumorigenesis and chemoprevention studies in carcinogen-treated rats. J Mammary Gland Biol 1996, 1, 37-49.
14. McCormick DL, Adamowski CB, Fiks A, Moon RC. Life time dose response relationship for mammary tumor induction by a single administration of MNU. Cancer Res 1981, 41, 1690-1694.
15. Moon RC, Mehta RG. Cancer chemoprevention by retinoids. Methods in Enzymol 1990, 190, 395-406.
16. Thompson HJ, McGinley J, Rothhammer K, Singh M. Rapid induction of mammary intraductal proliferation ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats by MNU. Carcinogenesis 1995, 16, 2407-2411.
17. Thompson HJ, Adlakha H. Dose responsive induction of mammary gland carcinomas by intraperitoneal injections of MNU. Cancer Res 1991, 51, 3411-3415.
18. Moon RC, Mehta RG. Chemoprevention of mammary cancer by retinoids. In Kuroda Y, Shankel DM, Waters M, eds. Antimutagenesis and Anticarcinogenesis Mechanisms II. New York, NY, Plenum Press, 1990, 213-224.
19. Moon RC, Thompson HJ, Becci PJ, et al. N-4-[Hydroxyphenyl]retinamide a new retinoid for prevention of breast cancer in the rat. Cancer Res 1979, 39, 1339-1346.
20. McCormick DL, Burns FJ, Albert RE. Inhibition of rat mammary carcinogenesis by a short dietary exposure to retinyl acetate. Cancer Res 1980, 40, 1140-1143.
21. Boone CW, Kelloff GJ, Malone WE. Identification of candidate chemopreventive agents and their evaluation in animal models and human clinical trials. A review. Cancer Res 1990, 50, 2-9.
22. McCormick DL, Mehta RG, Thompson M, Dinger N, Caldwell JA, Moon RC. Enhanced inhibition of mammary carcinogenesis by combined treatment with 4-HPR and ovariectomy. Cancer Res 1982, 42, 508-512.
23. Ip M, Darcy KM. Three dimensional mammary primary culture model systems. J Mammary Gland Biol 1996, 1, 91-111.
24. Agadir A, Lazzaro G, Zheng Y, Zhang XK, Mehta RG. Resistance of HBL-100 human breast epithelial cells to vitamin D action. Carcinogenesis 1999, 20, 577-582.
25. Jinno H, Steinner MG, Mehta RG, Osborne MP, Telang NT. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-4-hydroxyphenyl-retinamide. Carcinogenesis 1999, 20, 229-236.
26. Mehta RG, Moriarty RM, Mehta RR, et al. Prevention of preneoplastic mammary lesion development by a novel vitamin D analog la-hydroxyvitamin D5. J Natl Cancer Inst 1997, 89, 212-218.
27. Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol a natural product derived from grapes. Science 1997, 275, 218-220.
28. Mehta RG, Liu J, Constantinou AI, et al. Cancer chemopreventive activity of brassinin a phytoalexin from cabbage. Carcinogenesis 1995, 16, 399-404.
29. Gerhauser C, Mar W, Lee SK, et al. Rotenoids mediate potent cancer chemopreventive activity through transcriptonal regulation of ornithine decarboxtlase. Nature Medicine 1995, 1, 260-266.
30. Mehta RG, Williamson E, Koeffler HP. A ligand of peroxisome proliferator-activated receptor y, retinoids and prevention of preneoplastic mammary lesions. J Natl Cancer Inst 2000, 92, 418-423.
31. Grubbs CJ, Eto I, Juliana M, Hardin JM, Whiteker LM. Effects of retinyl acetate and 4-HPR on initiation of chemically induced mammary tumors. Anticancer Res 1990, 10, 661-666.
32. Moon RC, Grubbs CJ, Sporn MB, Goodman DG. Retinyl acetate inhibits mammary carcinogenesis induced by N-methyl-Nnitrosourea. Nature 1977, 267, 620-622.
33. Thompson HJ, McGiley JN, Wolfe P, Singh M, Steele VE, Kelloff GJ. Temporal sequence of mammary intraductal proliferation ductal carcinoma in situ and adenocarcinoma induced by MNU in rats. Carcinogenesis 1998, 19, 2181-2185.
34. Ip C, Thompson HJ, Ganther HE. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. Cancer Epidemiol Biomarkers Prev 2000, 9, 49-54.
35. Suh N, Wang Y, Williams CR, et al. A new ligand for peroxisome proliferator activated receptor gama (PPARgamma), GW7845, inhibits rats mamary carcinogenesis. Cancer Res 1999, 59, 5671-5673.
36. McCormick DL, Becci PJ, Moon RC. Inhibition of mammary gland and urinary bladder carcinogenesis by a retinoid ad a maleic anhydride-divinyl ether copolymer (MVE-2). Carcinogenesis 1982, 3, 1473-1477.
37. Moon RC, Steele VE, Kelloff GJ, et al. Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremefene, RU 16117, tamoxifen, aminoglutathamide and progesterone. Anticancer Res 1994, 14, 889-893.
38. Moon RC, KelloffGJ, Detrisac CJ, Steele VE, Thomas CF, Sigman CC. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen. Anticancer Res 1992, 12, 1147-1153.
39. Anzano MA, Byers SW, Smith JM, et al. Prevention of breast cancer in the rat with 9-cis retinoic acid as a single agent and in combination with tamoxifen. Cancer Res 1994, 54, 4614-4617.
40. Ip C, Ganther HE. Combination of blocking agents and suppressing agents in cancer prevention. Carcinogenesis 1991, 12, 365-367.
41. Anzano MA, Smith JM, Uskokovic MR, et al. l-alpha,25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analog) for prevention of breast cancer in rat. Cancer Res 1994, 54, 1653-1656.
42. Abbou-Issa H, Koolemans-Beynen A, Minton JP, Webb TE. Synergistic interaction between 13-cis retinoic acid and glucarate activity against rat mammary tumor induction and MCF-7 cells. Biochem Biophys Res Com 1989, 29, 1369.
43. Gotoh T, Yamada K, Ito A, Yin H, Kataoka T, Dohi K. Chemoprevention of MNU-induced rat mammary cancer b miso and tamoxifen alone and in combination. Jpn J Cancer Res 1998, 89, 487-495.
44. Kothari A, Borges A, Kothari L. Chemoprevention by melatonin and combined melatonin-tamoxifen therapy of second generation MNU-induced mammary tumors in rats. Eur J Cancer Prev 1995, 4, 497-500.